United States HR 5260: Reduced Costs and Continued Cures Act

Status: Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. (as of 2022-11-01)

State: United States · Session: 117 · Bill: HR 5260

Sponsors: Scott H. Peters, J. Luis Correa, Josh Gottheimer, Kathleen M. Rice, Kurt Schrader, Stephanie N. Murphy

View United States HR 5260 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.